Neuropharmacology of St. John's wort (Hypericum)

Annals of Pharmacotherapy

Volumn 32, Issue 11, 1998, Pages 1201-1208

  Bennett Jr , Dean A ^a,b   Phun, Lisa ^a   Polk, Jeffrey F ^a   Voglino, Susan A ^a,c   Zlotnik, Vladislau ^a   Raffa, Robert B ^a,d  

^a TEMPLE UNIVERSITY   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c Rite Aid   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressive agents; Herbal medicine; St. John's wort

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANTIDEPRESSANT AGENT; CATECHOL METHYLTRANSFERASE; HYPERICIN; PSEUDOHYPERICIN; SEROTONIN;

CLINICAL TRIAL; DEPRESSION; DRUG DETERMINATION; DRUG METABOLISM; ENZYME INHIBITION; HUMAN; HYPERICUM PERFORATUM; META ANALYSIS; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROTONIN UPTAKE;

EID: 14444285482     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18026     Document Type: Review

References (38)

1. Upton R, Bunting D, Butterweck V, Cott J, Gatherum DM. Graff A, et al. St. John's wort Hypericum perforatun. Santa Cruz, CA: American Herbal Pharmacopoeia, 1997:1-32.
2. Wells BG, Mandos LA, Hayes PE. Depressive disorders. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacology: a pathophysiologic approach. Stamford, CT: Appleton & Lange, 1997:1395-417.
3. Mood disorders. In: Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association, 1994:317-91.
4. Laird LK, Benefield WH. Mood disorders I: major depressive disorders. In: Young LY, Koda-Kimble MA, eds. Applied therapeutics: the clinical use of drugs. 6th ed. Vancouver, WA: Applied Therapeutics, Inc., 1995; 76:1-76:28.
5. Hollister LE. Antidepressant agents. In: Katzung BG, ed. Basic & clinical pharmacology. 6th ed. Norwalk, CT: Appleton & Lange, 1995:448-59.
6. Saklad JJ, Curtis JL. Psychiatric disorders in children, adolescents, and people with developmental disabilities. In: Young LY, Koda-Kimble MA, eds. Applied therapeutics: the clinical use of drugs. 6th ed. Vancouver, WA: Applied Therapeutics, Inc., 1995;78:1-78:19.
7. Jackson SW. Melancholia in ancient Greece and Rome. In: Melancholia and depression. New Haven, CT: Yale University Press, 1986:29-43.
8. Tellenbach H. Historical perspectives defining the problem: a backward glance ahead. In: Giorgi A, ed. Melancholy. Pittsburgh: Duquesne University Press, 1980:1-16.
9. Payk TR. Treatment of depression. J Geriatr Psychiatry Neurol 1994;7 (suppl 1):S3-5.
10. Paykel ES. Historical overview of outcome of depression. Br J Psychiatry 1994;165(suppl 26):6-8.
11. St. John's wort. Med Lett 1997;39:107.
12. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St. John's wort for depression - an overview and meta-analysis of randomized clinical trials. BMJ 1996;313:253-8.
13. Harrer G, Schulz V. Clinical investigation of antidepressant effectiveness of Hypericum. J Geriatr Psychiatry Neurol 1994;7(suppl 1):S6-8.
14. Bloomfield HH, Nordfors M, McWilliams P. Hypericum & depression. Los Angeles: Prelude Press, 1996:49-197.
15. Woelk H, Burkard G, Grünwald J. Benefits and risks of the Hypericum extract LI 160: drug monitoring study with 3250 patients. J Geriatr Psychiatry Neurol 1994;7(suppl 1):S34-8.
16. Martinez B, Kasper S, Ruhrmann S, Möller H-J. Hypericum in the treatment of seasonal affective disorders. J Geriatr Psychiatry Neurol 1994;7 (suppl 1):S29-33.
17. Wagner H, Bladt S. Pharmaceutical quality of Hypericum extracts. J Geriatr Psychiatry Neurol 1994;7(suppl 1):S65-8.
18. Piperopoulos G, Lotz R, Wixforth A, Schmierer T, Zeller K-P. Determination of naphthodianthrones in plant extracts from Hypericum perforatum L. by liquid chromatography-electrospray mass spectrometry. J Chromatogr B 1997;695:309-16.
19. Bladt S, Wagner H. Inhibition of MAO by fractions and constituents of Hypericum extract. J Geriatr Psychiatry Neurol 1994;7(suppl 1):S57-9.
20. Thiede H-M, Walper A. Inhibition of MAO and COMT by Hypericum extracts and hypericin. J Geriatr Psychiatry Neurol 1994;7(suppl 1):S54-6.
21. Perovic S, Müller WEG. Pharmacological profile of Hypericum extract: effect on serotonin uptake by postsynaptic receptors. Arzneimittelforschung 1995;45:1145-8.
22. Müller WEG, Rossol R. Effects of Hypericum extract on the expression of serotonin receptors. J Geriatr Psychiatry Neurol 1994;7(suppl 1):S63-4.
23. Thiele B, Brink I, Ploch M. Modulation of cytokine expression by Hypericum extract. J Geriatr Psychiatry Neurol 1994;7(suppl 1|)S60-2.
24. Müller WE, Schäfer C. Johanniskraut: in-vitro Studie über Hypericum-Extrakt, Hypericin und Kämpferol. Deutsche Apotheker Zeitung 1996; 136:1015-22.
25. Staffeldt B, Kerb R, Brockmöller J, Ploch M, Roots I. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the Hypericum perforatum extract LI 160 in healthy volunteers. J Geriatr Psychiatry Neurol 1994;7(suppl 1):S47-53.
26. Leonard BE. Fundamentals of psychophannacology. 2nd ed. Chichester, England: John Wiley & Sons, 1997:345-9.
27. Stone TW. Neuropharmacology. Oxford, England: WH Freeman, 1995: 72-3.
28. Raffa RB. Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals a receptor binding. Life Sci/Pharmacol Letts 1998;62:PL265-70.
29. Raffa RB. A novel approach to the pharmacology of analgesics. Am J Med 1996;101 (suppl 1A):40S-6S.
30. Demisch L, Nispel J, Sielaff T, Gebhart P, Köhler C, Pflug B. Influence of subchronic Hyperforat administration on melatonin production. Arbeitsgemeinschaft für Neuro- und Psychopharmakologie-symposium Abstracts, Nürnberg 1991.
31. Schulz H, Jobert M. Effects of Hypericum extracts on the sleep EEG in older volunteers. J Geriatr Psychiatry Neurol 1994;7(suppl 1):S39-43.
32. Johnson D, Ksciuk H, Woelk H, Sauerwein-Giese E, Frauendorf A. Effects of Hypericum extract LI 160 compared with maprotiline on resting EEG and evoked potentials in 24 volunteers. J Geriatr Psychiatry Neurol 1994;7(suppl 1):S44-6.
33. Winterhof H, Butterweck V, Nahrstedt A, Gumbinger HG, Schulz V, Erping S, et al. Phytopharmaka in Forschung unf klinischer Anwendung. Darmstadt, Germany: Steinkopff Verlag GmbH & Co. KG, 1995:S39-52.
34. Nielsen M, Frøkjær S, Braestrup C. High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitro. Biochem Pharmacol 1988;37:3285-7.
35. Smith RS. The macrophage theory of depression. Med Hypoth 1991;35: 298-306.
36. Shipochliev T, Dimitrov A, Aleksandrova E. Anti-inflammatory action of a group of plant extracts (Bulgarian). Veterinarno-Meditsinski Nauki 1981;18:87-94.
37. Zakharova NS, Remova TN, Shepeleva IB, Bazhanova IG, Britsina MV. Action of plant extracts on the natural immunity indices of animals (Russian). Zhurnal Mikrobiol, Epidemiol i Immunobiol 1986;4:71-5.
38. Okpanyi SN, Weischer ML. Animal experiments on the psychotropic action of a Hypericum extract. Arzneimittelforschung 1987;37:10-3.